Terumo's Interventional Systems division is a global leader in cardiovascular care, providing low invasive devices for the treatment of coronary artery disease. Our philosophy is to deliver high quality devices with unique and innovative technology. We offer a comprehensive device portfolio including products for the diagnosis and treatment of coronary artery disease.
Featured product: Ultimaster™ Sirolimus Eluting Coronary Stent System
60 MVD patients with OFDI, single arm, primary endpoint TLF @ 12M. Published
One of the largest, prospective worldwide registries
Featured products: Ultimaster™ Sirolimus Eluting Coronary Stent System, Ultimaster™ Tansei™ Sirolimus Eluting Coronary Stent System
500 STEMI patients, randomised 1:3 vs Kaname BMS, primary endpoint TVF 12M. Published and completed
20 patients, single arm, pharmocokinetics. Published.
This webpage can include promotional content regarding one or several products of Terumo Europe, or some procedures concerning the use or implantation of such products. This webpage is exclusively intended for healthcare professionals and is in no event directed to the general public
This is HCP only content